missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BRI3BP Antibody, Novus Biologicals™

BRI3BP Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

£362.00

Specifications

Antigen BRI3BP
Applications Western Blot
Classification Polyclonal
Conjugate Unconjugated
Host Species Rabbit
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18242545
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP1-62385 		100 μL
£362.00
100µL
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

BRI3BP Polyclonal specifically detects BRI3BP in Human samples. It is validated for Western Blot.
Specifications

Specifications

BRI3BP
Polyclonal
Rabbit
Q8WY22
140707
Synthetic peptides corresponding to BRI3BP(BRI3 binding protein) The peptide sequence was selected from the C terminal of BRI3BP. Peptide sequence GFYWRSSPSGPSNPSNPSVEEKLEHLEKQVRLLNIRLNRVLESLDRSKDK.
Primary
Western Blot
Unconjugated
RUO
BNAS1, BRI3 binding protein, BRI3-binding protein, Cervical cancer 1 proto-oncogene-binding protein KG19, cervical cancer oncogene binding protein, HCCR-1, HCCR-2, HCCRBP-1, KG19I3-binding protein
BRI3BP
IgG
28 kDa
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.